Hemophilia Clinical Trials

A listing of Hemophilia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 107 clinical trials
None
Hemlibra in Mild Hemophilia A

laboratory parameters in the mild hemophilia A male patient population with endogenous altered FVIII (baseline FVIII activity of >5% to 30%). The safety and hemostatic efficacy of Hemlibra (emicizumab) in

  • 0 views
  • 21 Oct, 2021
  • 1 location
None
The Hemophilia Inhibitor Prevention Trial

patients with severe hemophilia A.

  • 0 views
  • 21 Oct, 2021
  • 3 locations
None
The Hemophilia Inhibitor Eradication Trial

inhibitors in severe hemophilia A.

  • 0 views
  • 13 Nov, 2021
  • 2 locations
None
A Pharmacokinetic and Clotting Activity Study of FVIII-PEGLip

The purpose of this study is to demonstrate that PEGylated liposomes (PEGLip) can shield FVIII from the immune system and inhibitors, and therefore provide a prophylactic FVIII replacement therapy for patients with inhibitors to FVIII.

  • 0 views
  • 28 Oct, 2021
  • 5 locations
None
HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor

hemophilia A patients (baseline FVIII level <40%) with and without inhibitors with hemophilic pseudotumors; secondary outcomes will assess changes in quality of life and activity level in treated patients

  • 0 views
  • 25 Jun, 2021
  • 1 location
None
Safety Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A

Primary Objective: To evaluate the safety of BIVV001 in previously treated pediatric subjects with hemophilia A Secondary Objectives: To evaluate the

  • 0 views
  • 24 Jul, 2021
  • 31 locations
None
Study to Evaluate the Efficacy and Safety of Valoctocogene Roxaparvovec With Prophylactic Steroids in Hemophilia A

This Phase III clinical study will evaluate the safety and effectiveness of valoctocogene roxaparvovec in combination with prophylactic corticosteroids in patients with severe hemophilia A.

  • 0 views
  • 24 Jul, 2021
  • 11 locations
None
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A

Primary Objective: To evaluate the long-term safety of BIVV001 in previously treated subjects with hemophilia A Secondary Objectives: To evaluate the

  • 0 views
  • 08 Nov, 2021
  • 18 locations
None
Safety, Efficacy and PK of BIVV001 in Pediatric Patients With Hemophilia A

Primary Objective: To evaluate the safety of BIVV001 in previously treated pediatric subjects with hemophilia A Secondary Objectives: To evaluate the

  • 0 views
  • 05 Nov, 2021
  • 31 locations
None
Long-term Safety and Efficacy of Efanesoctocog Alfa (BIVV001) in Previously Treated Patients With Hemophilia A

Primary Objective: To evaluate the long-term safety of BIVV001 in previously treated subjects with hemophilia A Secondary Objectives: To evaluate the

  • 0 views
  • 05 Nov, 2021
  • 40 locations